88IV - PR Newswire Asia's news - Health Care/Hospital


Zhongchao Inc. Announces 1-for-31 Share Consolidation SHANGHAI , June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with ... 2026-06-04T Banking/Financial Service Health Care/Hospital
Innovative Drug Update \| Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10 SHENZHEN, China , June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market Everest Medicines has obtained exclusive rights for the clinical development and commercialization of Bejescin ® (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast ... 2026-06-04T Health Care/Hospital Medical/Pharmaceuticals
Waterdrop Inc. to Report First Quarter 2026 Financial Results on June 16, 2026 BEIJING , June 4, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service ... 2026-06-04T Banking/Financial Service Computer/Electronics Health Care/Hospital
World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA SAN FRANCISCO and SUZHOU, China , June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma GUANGZHOU, China , June 4, 2026 /PRNewswire/ -- Lupeng Pharmaceutical today announced that the National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
111, Inc. Announces First Quarter 2026 Unaudited Financial Results Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year ... 2026-06-04T Health Care/Hospital Medical/Pharmaceuticals Retail
TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus. ... 2026-06-04T Banking/Financial Service Health Care/Hospital Telecommunications
2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership - Vital Strategies NEW YORK , June 4, 2026 /PRNewswire/ -- A formidable coalition of global health experts and advocates is demanding FIFA commit to ending its partnership with Coca-Cola by 2030. The Kick Big Soda ... 2026-06-04T Entertainment Health Care/Hospital Retail
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S. SEOUL, South Korea , June 4, 2026 /PRNewswire/ -- MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct ... 2026-06-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital